ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 102 filers reported holding ADURO BIOTECH INC in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $22,000 | -95.8% | 18,900 | -73.1% | 0.00% | -89.3% |
Q4 2017 | $527,000 | +2.5% | 70,300 | +69.8% | 0.03% | -33.3% |
Q3 2016 | $514,000 | -79.9% | 41,400 | -79.3% | 0.04% | -83.8% |
Q1 2016 | $2,563,000 | +17.7% | 200,100 | +158.5% | 0.26% | -6.5% |
Q4 2015 | $2,178,000 | – | 77,400 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |